Abstract
The concept of nonablative fractional photothermolysis was introduced almost a decade ago to address the main shortcomings of non-fractionated, nonablative devices available at that time. By delivering laser light as a series of fractionated columns, the 1550 nm Er:doped laser was able to achieve greater penetration depths and spare areas of normal intervening skin, allowing epidermal contribution to a more rapid healing process. Yet these devices, despite their more predictable outcomes, were felt to lack the efficacy of complete epidermal ablation, spawning the expansion of fractionated devices to include ablative wavelengths, which have proven more consistent and safer than pre-existing pulsed ablative devices. This article will summarize an ever-expanding literature to facilitate the application of both nonablative and ablative fractional technologies in clinical practice, and establishes grounds by which varying fractional lasers can be compared.
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.